药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Biperiden
Clobetasol propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Estramustine.
Biperiden
Brentuximab vedotin
The risk or severity of adverse effects can be increased when Estramustine is combined with Brentuximab vedotin.
Biperiden
Bosutinib
The risk or severity of adverse effects can be increased when Estramustine is combined with Bosutinib.
Biperiden
Pazopanib
The risk or severity of adverse effects can be increased when Estramustine is combined with Pazopanib.
Biperiden
Temsirolimus
The risk or severity of adverse effects can be increased when Estramustine is combined with Temsirolimus.
Biperiden
Everolimus
The risk or severity of adverse effects can be increased when Estramustine is combined with Everolimus.
Biperiden
Colchicine
The risk or severity of adverse effects can be increased when Estramustine is combined with Colchicine.
Biperiden
Paclitaxel
The risk or severity of adverse effects can be increased when Estramustine is combined with Paclitaxel.
Biperiden
Emapalumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Emapalumab.
Biperiden
Siponimod
The risk or severity of adverse effects can be increased when Estramustine is combined with Siponimod.
Biperiden
Ibrutinib
The risk or severity of adverse effects can be increased when Estramustine is combined with Ibrutinib.
Biperiden
Siltuximab
The risk or severity of adverse effects can be increased when Estramustine is combined with Siltuximab.
Biperiden
Secukinumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Secukinumab.
Biperiden
Certolizumab pegol
The risk or severity of adverse effects can be increased when Estramustine is combined with Certolizumab pegol.
Biperiden
Golimumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Golimumab.
Biperiden
Rilonacept
The risk or severity of adverse effects can be increased when Estramustine is combined with Rilonacept.
Biperiden
Tocilizumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Tocilizumab.
Biperiden
Canakinumab
The risk or severity of adverse effects can be increased when Estramustine is combined with Canakinumab.
Biperiden
Apremilast
The risk or severity of adverse effects can be increased when Estramustine is combined with Apremilast.
Biperiden
Afelimomab
The risk or severity of adverse effects can be increased when Estramustine is combined with Afelimomab.